New India Biopharma Private Limited, a active private limited company, was established on 08 March 2011 in New Delhi, Delhi, India. Engaging in forex services within the manufacturing sector, it holds CIN: U51397DL2011PTC215424. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.71 Cr.
It upholds a compliant status. Its leadership includes Randeep Jaikaria Singh (Director), Nergish Dadi Mistry (Additional Director), Rakesh Ahuja (Director). Past directors included Randeep Jaikaria Singh, Jaswant Raju Singh, Sudhir Sharma. It holds ₹0.85 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Altf Okhla 101, Room No- Mr1,, Plot No-101, Mathura Road, Okhla,, New Delhi, Delhi, 110044.
U51397DL2011PTC215424
215424
08 March 2011
₹2.00 Cr
₹1.71 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into New India Biopharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Randeep Jaikaria Singh | Director | 14 Dec 2018 | Current |
| Nergish Dadi Mistry | Additional Director | 01 Jan 2025 | Current |
| Rakesh Ahuja | Director | 13 Apr 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 13 Mar 2017 | Past |
| Pramod Abcsdd | Additional Director | 08 Apr 2014 | Past |
| Pramod Abcsdd | Director | 01 Dec 2021 | Past |
| Pramod Abcsdd | Additional Director | 26 Nov 2021 | Past |
| Pramod Abcsdd | Director | 10 Aug 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
New India Biopharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 59.25% increase. The company also saw a substantial fall in profitability, with a 64.88% decrease in profit. The company's net worth observed a substantial decline by a decrease of 157.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, New India Biopharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹850,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Dec 2024 | Hdfc Bank Limited | ₹0.85 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with New India Biopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of New India Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New India Biopharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nergish Dadi Mistry was appointed as a Additional Director was appointed as a Additional Director on 01 Jan 2025 & has been associated with this company since 1 year 13 days . was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 0.09 Cr with Charge ID 101017338 was registered on 11 Dec 2024. was recorded as a recent event.
New India Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity New India Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on Rakesh Ahuja was appointed as a Director was appointed as a Director on 13 Apr 2021 & has been associated with this company since 4 years 9 months . was documented.
Progress on Randeep Jaikaria Singh was appointed as a Director was appointed as a Director on 14 Dec 2018 & has been associated with this company since 7 years 1 month . was documented.
The CIN of New India Biopharma Private Limited is U51397DL2011PTC215424.
New India Biopharma Private Limited is headquartered at Altf Okhla 101, Room No- Mr1,, Plot No-101, Mathura Road, Okhla,, New Delhi, Delhi, 110044.
New India Biopharma Private Limited was incorporated on 08 March 2011.
The current directors of New India Biopharma Private Limited are
The primary industry of New India Biopharma Private Limited is Manufacturing.
New India Biopharma Private Limited is unlisted.
The authorized capital of New India Biopharma Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.71 Cr.
The compliance status of New India Biopharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX